$CBRS

Feldman Andrew D. sold $7.9M of CBRS

Feldman Andrew D. (CEO, President) sold 37,441 shares of Cerebras Systems Inc. (CBRS) at an average of $210.46 ($199.18–$216.62, $7.88M total) across 16 trades on 2026-09-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Feldman Andrew D.
Published Sep 9, 2026, 12:17 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 12:34 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CBRS
Bearish
medium confidence
Mentioned
$CBRS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBRSBearishLow
01

Why it matters

The reduction in insider ownership may be interpreted by some traders as a lack of confidence, prompting modest sell orders. However, the planned nature of the trade reduces the likelihood of a sudden price shock.

02

Market read

The filing is a primary source of new information for CBRS shareholders and may generate modest short‑term trading activity.

03

What to watch

Potential upcoming product announcements or financing rounds could offset any short‑term pressure from the sale.

Relevance 5/10Novelty 5/10Timing: post‑market filing on Sep 8, 2026

Background

Form 4 filings provide the first public disclosure of insider transactions. This filing reports a CEO‑initiated sale under a pre‑arranged 10b5‑1 plan.

Company-level read

Ticker impact

$CBRSBearishMedium confidence
Context

CEO Andrew Feldman sold 37,441 shares for $7.9 M via a 10b5‑1 plan, reducing his stake to 16,853 shares.

Expected impact

Likely modest downward pressure in the near term as the market digests the CEO's reduction of holdings.

Evidence & confidence

A $7.9 M sale by the CEO is material for a micro‑cap, but the amount is not large enough to trigger a sharp move; the 10b5‑1 plan indicates pre‑planned execution rather than a reaction to news.

Market effects

Minimal impact on the AI‑hardware sector; insider sales are common and do not alter sector fundamentals.

Limited to U.S. investors tracking micro‑cap AI hardware stocks.

Low; the filing is unlikely to affect broader market sentiment.

Counterpoint

The sale could be a routine liquidity event and not indicative of negative outlook; price may remain stable.

Key entities

  • Cerebras Systems Inc.

    AI‑hardware manufacturer listed on NASDAQ under ticker CBRS.

  • Andrew D. Feldman

    CEO and President of Cerebras Systems, reporting the insider sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CBRSMed

Cerebras (CBRS) Plants A 165 MW Flag In Finland While Still Losing Money

Cerebras Systems (CBRS) announced a new AI data center in Finland with partner Compute Nordic Finland, set to reach 165 MW capacity. The project is backed by contracts and will be built in stages. Cerebras reported a 281% increase in cloud revenue for the quarter, but still operates at a loss. The company raised its full-year outlook but expects lower margins in the third quarter. Hedge fund ownership increased significantly, while short interest remains high.

$CBRSHighAI 8/10

Cerebras Drops 19% in 3 Months: Buy, Sell or Hold the Stock?

Cerebras Systems (CBRS) shares fell 19% in 3 months due to profitability concerns, margin pressure, and competition. Q3 2026 revenue guidance is $214-$216M, with margins expected to decline. The company faces customer concentration risks and competition from NVIDIA, AMD, and Intel. Despite strong RPO and expansion plans, near-term challenges persist. Analysts see a 56.93% upside potential.

$CBRSMedAI 8/10

Cerebras Has a $25.4 Billion Backlog, and One OpenAI Agreement Is Behind Much of It

Cerebras Systems reported Q2 adjusted revenue of $209.9M, up 103% YoY, with a $25.4B backlog driven by an OpenAI agreement. The company raised its full-year outlook to $880M-$890M. OpenAI's deal accounts for most of the backlog, with revenue recognition expected over several years. Cerebras' stock is down 44% from its 52-week high, trading at a market cap of ~$51B.

$CBRSHighAI 8/10

CBRS Stock Surges 68% On Nasdaq Debut: Cathie Wood's ARK Buys Shares While Trimming TSMC, AMD

Cerebras Systems (CBRS) shares surged 68% on their Nasdaq debut, closing at $311.07, with a market cap of $95B. ARK ETFs bought 105,616 shares, while trimming stakes in TSMC and AMD. The IPO raised $5.6B, with strong demand highlighting investor interest in AI hardware. CBRS reported $510M in 2023 sales, up from $290.3M in 2024, and partners with OpenAI, Meta, AWS, and IBM.